26.12.2012 Views

Toxicology of Industrial Compounds

Toxicology of Industrial Compounds

Toxicology of Industrial Compounds

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

182 MOLECULAR APPROACHES TO ASSESS CANCER RISKS<br />

Management <strong>of</strong> cancer risks (key requirements)<br />

The management <strong>of</strong> toxicological risks implies a capacity to control<br />

exposures within acceptable safety limits. Effective control is, therefore,<br />

dependent not only on the qualitative detection and identification <strong>of</strong><br />

hazardous chemicals but also on a capacity to determine human exposure<br />

and to evaluate the health risks. This last requirement necessitates a<br />

knowledge <strong>of</strong> potency, i.e. quantitative human dose-response relationships.<br />

In the case <strong>of</strong> genotoxic chemicals, the relevant data reside in the very low<br />

region <strong>of</strong> the dose-response curve.<br />

The concept <strong>of</strong> acceptable risk is readily accepted when applied to the<br />

many classes <strong>of</strong> toxic chemicals operating by a thresholded mechanism<br />

indicative <strong>of</strong> the virtual absence <strong>of</strong> risk at sub-threshold doses. Absolute<br />

safety margins for genotoxic chemicals cannot be guaranteed (vide supra)<br />

leading to the adoption <strong>of</strong> conservative safety measures. Indeed, cursory<br />

analysis might suggest that quantitative risk data are not required for the<br />

effective management <strong>of</strong> cancer risks associated with genotoxic chemicals.<br />

Thus, it is generally accepted that human contact with carcinogens should<br />

be minimised. Purely qualitative identification <strong>of</strong> the hazard would permit<br />

the design <strong>of</strong> measures to limit human exposure and minimise carcinogenic<br />

impact. Indeed, a purely qualitative indication <strong>of</strong> genotoxicity can be an<br />

absolute deterrent to the development <strong>of</strong> new products. Nevertheless,<br />

certain exposures, e.g. to indigenous genotoxic chemicals and natural food<br />

components, are unavoidable. Furthermore, measures to reduce exposures<br />

to ‘avoidable’ genotoxic hazards, e.g. certain combustion products, key<br />

industrial base chemicals and intermediates, are <strong>of</strong>ten difficult and costly.<br />

Quantitative risk assessment is needed to prioritise these hazards and, most<br />

importantly, to determine safety margins. Certainly a failure to determine<br />

carcinogenic potency would lead to uncertainty about the adequacy <strong>of</strong><br />

safety margins and, probably, to unnecessary measures to further reduce<br />

exposures. Thus, despite their additive and cumulative actions, even<br />

genotoxic chemicals can pose a negligible health risk. Of course, the<br />

definition <strong>of</strong> a negligible, i.e. acceptable, risk is a socio-political judgement<br />

which nevertheless has to be realistic in the case <strong>of</strong> unavoidable hazards<br />

and achievable in the case <strong>of</strong> avoidable hazards.<br />

Detection <strong>of</strong> genotoxic carcinogens<br />

Concerns about genotoxic hazards have provided an incentive for the<br />

development <strong>of</strong> a broad range <strong>of</strong> rapid tests to detect intrinsic genotoxic<br />

activity or potential. The principal aim <strong>of</strong> these approaches is to predict<br />

carcinogenic activity or, more accurately, cancer initiating activity. The<br />

most widely used tests are the coupled microsomal-microbial mutation<br />

assays developed by Ames et al. (1973). However, such approaches are

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!